Calcium phosphate deposit

Calcium phosphate deposits refer to accumulations of calcium and phosphate minerals that can occur physiologically (such as formation of bone hydroxyapatite) or pathologically (such as in soft tissues, blood vessels, or kidneys)[1][6][7]. The process is tightly regulated by hormonal and cellular mechanisms, including the activities of osteoblasts and mediators such as parathyroid hormone (PTH), vitamin D, and fibroblast growth factor 23 (FGF23). In bone, amorphous calcium phosphate is first deposited in matrix vesicles and then develops into crystalline hydroxyapatite, mediated by cellular and enzymatic processes[1][5]. In pathological situations, abnormal calcium and phosphate serum levels or local tissue factors (including inflammation and tissue injury) may promote the precipitation of calcium phosphate, leading to calcification and disease[6][7]. Calcium phosphate deposits themselves do not act as a receptor, enzyme, transporter, or classical therapeutic target, but rather are the result of dysregulated mineral homeostasis, where therapy is directed at preventing deposition or promoting dissolution.

Other names

Calcium phosphate crystalsoft tissue calcificationcalcific depositcalcium orthophosphate deposit

Inhibition of crystal nucleation and growth (bisphosphonates) Reduction of serum phosphate (phosphate binders) Modulation of calcium and phosphate regulatory pathways (calcimimetics, vitamin D analogs) [6][7] Dissolution of deposits (experimental agents such as sodium thiosulfate) [7]